Haudebourg, Anne-Fleur
Moncomble, Elsa
Lesimple, Arnaud
Delamaire, Flora
Louis, Bruno
Mekontso Dessap, Armand
Mercat, Alain
Richard, Jean-Christophe
Beloncle, François
Carteaux, Guillaume
Article History
Received: 2 June 2023
Accepted: 4 July 2023
First Online: 7 July 2023
Declarations
:
: This study was set in compliance with Helsinki Declaration and was approved by the ethics committee “CPP Sud Ouest et Outre Mer III” (2018-A00867–48) for DriVV cohort, and by “CPP Sud-Est I” for PREMIER cohort. According to the French law, non-opposition to participate in the study from the patient or his/her next of kin was collected prior to inclusion. Experiments on Thiel embalmed cadavers (TEC) were conducted in accordance with Canadian regulation and approved by the ethics committee of the UQTR (SCELERA-19-01-PR02).
: Not applicable.
: A. Lesimple is PhD student in the Med<sub>2</sub>Lab partially funded by Air Liquide Medical Systems. A. Mekontso Dessap reports grants from Fischer Paykel, Baxter, Philips, Ferring and GSK, personal fees from Air Liquide, Baxter, Amomed, Getingue and Addmedica, outside the submitted work. A. Mercat reports personal fees from Faron Pharmaceuticals, Air Liquide Medical Systems, Pfizer, Resmed and Draeger and grants and personal fees from Fisher and Paykel and Covidien, outside this work. JC Richard reports part time salary for research activities (Med<sub>2</sub>Lab) from Air Liquide Medical Systems and Vygon. F. Beloncle reports personal fees from Löwenstein Medical, Air Liquide Medical Systems and research support from Covidien, GE Healthcare and Getinge Group, outside this work. G. Carteaux reports personal fees from Air Liquide Medical System, GE Healthcare, Dräger, Fisher and Paykel, Medtronic and Löwenstein, outside the submitted work. All other authors declare no competing interests.